Companies & Industry »Company News»Company News Details
Company News Details

BSE   31 Oct 14 | 11:02 AM

1410.00 -12.25 (-0.86%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   31 Oct 14 | 10:49 AM

1404.00 -17.5 (-1.23%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,377.50 (2.36%)
1 Month : Rs 1,308.10 (7.79%)
1 Year : Rs 663.05 (112.65%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
H D F C1,089.602.59
Maruti Suzuki3,324.902.55
Hero Motocorp3,096.852.20
St Bk of India2,696.202.20
Tata Steel483.401.90

Online Portfolio

You can create Online Portfolio here using the below button.